Sub-groups | Triglyceride group (mg/dl) | Per 1 mmol/L TG | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
<90 | 90-146 | 150-199 | ≥200 | |||||||
N* | RR (95% CI) | N* | RR† | N* | RR (95% CI) | N* | RR (95% CI) | N* | RR (95% CI) | |
Age (year) | ||||||||||
<50 | 3 | 0.84 (0.74, 0.96) | 4 | 1.00 | 4 | 1.21 (1.06, 1.40) | 3 | 1.20 (0.94, 1.53) | 10 | 1.11 (1.01, 1.22) |
≥50 | 7 | 0.85 (0.68, 1.05) | 8 | 1.00 | 8 | 1.08 (0.90, 1.30) | 5 | 1.30 (0.99, 1.69) | 12 | 1.15 (1.09, 1.22) |
P value | 0.956 | 0.338 | 0.664 | 0.488 | ||||||
Gender | ||||||||||
Male | 5 | 0.86 (0.67, 1.09) | 5 | 1.00 | 5 | 1.06 (0.89, 1.30) | 5 | 1.31 (1.12, 1.15) | 18 | 1.10 (1.04, 1.15) |
Female | 3 | 0.76 (0.64, 0.90) | 3 | 1.00 | 3 | 1.37 (1.09, 1.71) | 2 | 2.08 (1.44, 3.00) | 9 | 1.40 (1.22, 1.59) |
Mixed | 4 | 1.01 (0.65, 1.56) | 6 | 1.00 | 6 | 1.14 (1.10, 1.31) | 4 | 1.26 (0.99, 1.60) | 4 | 1.16 (1.08, 1.25) |
P value | 0.416 | 0.100 | 0.023 | 0.001 | ||||||
Follow-up (year) | ||||||||||
<12 | 6 | 0.81 (0.71, 0.91) | 6 | 1.00 | 6 | 1.01 (0.84, 1.19) | 4 | 1.25 (0.84, 1.84) | 11 | 1.14 (1.06, 1.22) |
≥12 | 4 | 0.79 (0.61, 1.02) | 4 | 1.00 | 6 | 1.27 (1.13, 1.44) | 4 | 1.25 (1.01, 1.54) | 11 | 1.11 (1.02, 1.21) |
P value | 0.473 | 0.025 | 0.992 | 0.694 | ||||||
Fast status | ||||||||||
Fast | 6 | 0.89 (0.71, 1.12) | 7 | 1.00 | 7 | 1.15 (0.98, 1.35) | 4 | 1.42 (1.22, 1.64) | 10 | 1.10 (1.04, 1.17) |
Nonfast | 3 | 1.00 (0.65, 1.54) | 4 | 1.00 | 4 | 1.14 (0.85, 1.46) | 4 | 1.11 (0.85, 1.46) | 7 | 1.12 (1.01, 1.23) |
Others§ | 1 | 0.80 (0.69, 0.93) | 1 | 1.00 | 1 | 1.15 (0.90, 1.45) | 0 | - | 5 | 1.19 (1.00, 1.41) |
P value | 0.646 | 0.843 | 0.122 | 0.821 | ||||||
Geographic location | ||||||||||
Europe/America | 7 | 0.86 (0.73, 1.01) | 8 | 1.00 | 8 | 1.17 (1.00, 1.37) | 5 | 1.22 (1.02, 1.55) | 18 | 1.11 (1.05, 1.17) |
Asia-Pacific | 3 | 0.80 (0.70, 0.92) | 4 | 1.00 | 4 | 1.20 (0.93, 1.35) | 3 | 1.20 (0.82, 1.77) | 4 | 1.26 (1.05, 1.52) |
P value | 0.509 | 0.729 | 0.847 | 0.205 | ||||||
Quality score | ||||||||||
<7 | 4 | 0.76 (0.65, 0.90) | 5 | 1.00 | 5 | 1.01 (0.80, 1.29) | 4 | 1.24 (0.91, 1.68) | 8 | 1.16 (1.04, 1.29) |
7-9 | 6 | 0.92 (0.77, 1.05) | 7 | 1.00 | 7 | 1.23 (1.09, 1.38) | 4 | 1.25 (0.98, 1.60) | 14 | 1.11 (1.04, 1.19) |
P value | 0.100 | 0.167 | 0.961 | 0.509 | ||||||
Sample size | ||||||||||
<4000 | 7 | 0.84 (0.70, 1.02) | 7 | 1.00 | 7 | 1.10 (0.91, 1.32) | 4 | 1.49 (1.21, 1.80) | 10 | 1.14 (1.06, 1.22) |
≥4000 | 3 | 0.83 (0.71, 0.97) | 5 | 1.00 | 5 | 1.18 (1.02, 1.38) | 4 | 1.12 (0.84, 1.45) | 12 | 1.13 (1.04, 1.22) |
P value | 0.910 | 0.541 | 0.100 | 0.883 | ||||||
Free of CVDs at baseline | ||||||||||
Yes | 6 | 0.85 (0.76, 0.96) | 7 | 1.00 | 7 | 1.12 (0.92, 1.36) | 6 | 1.20 (0.96, 1.50) | 13 | 1.11 (1.04, 1.20) |
No | 4 | 0.88 (0.67, 1.56) | 5 | 1.00 | 5 | 1.16 (1.00, 1.34) | 2 | 1.43 (1.16, 1.76) | 9 | 1.16 (1.09, 1.24) |
P value | 0.832 | 0.811 | 0.265 | 0.371 | ||||||
Adjustment | ||||||||||
Minimally | 4 | 0.72 (0.55, 0.94) | 5 | 1.00 | 5 | 1.44 (1.16, 1.78) | 4 | 1.52 (1.14, 2.02) | 7 | 1.15 (1.08, 1.22) |
Maximally | 4 | 0.87 (0.77, 0.98) | 5 | 1.00 | 5 | 1.24 (1.05, 1.46) | 4 | 1.29 (1.01, 1.65) | 7 | 1.05 (0.99, 1.11) |
P value | 0.207 | 0.271 | 0.398 | 0.033 | ||||||
Adjustment for TC | ||||||||||
Yes | 4 | 0.85 (0.77, 0.94) | 4 | 1.00 | 4 | 1.24 (1.07, 1.43) | 3 | 1.27 (0.94, 1.71) | 14 | 1.09 (1.03, 1.16) |
No | 6 | 0.82 (0.61, 1.09) | 8 | 1.00 | 8 | 1.06 (0.89, 1.26) | 5 | 1.25 (0.97, 1.61) | 8 | 1.21 (1.10, 1.34) |
P value | 0.810 | 0.169 | 0.927 | 0.078 | ||||||
Adjustment for HDL | ||||||||||
Yes | 3 | 0.81 (0.72, 0.91) | 3 | 1.00 | 3 | 1.23 (1.04, 1.47) | 1 | 1.52 (1.14, 2.02) | 3 | 1.10 (1.03, 1.19) |
No | 7 | 0.84 (0.68, 1.04) | 9 | 1.00 | 9 | 1.09 (0.94, 1.27) | 7 | 1.21 (1.00, 1.47) | 19 | 1.13 (1.06, 1.20) |
P value | 0.734 | 0.313 | 0.200 | 0.679 |